Objective: The rotational atherothrombectomy with Straub Rotarex(®) is a safe and efficient treatment of acute/subactute vascular occlusions. The purpose of this study was to evaluate the benefit of paclitaxel-coated angioplasty after rotational atherothrombectomy over an observation period of six months.
Materials And Methods: Overall, 29 patients were treated with the Rotarex catheter in combination with paclitaxel-coated angioplasty. All patients had acute/subacute and chronic occlusions of the superficial femoral artery (SFA) and/or popliteal arteries. The ankle-brachial index (ABI) was detected before the intervention, after the procedure, and after six months. Also clinical examination and ultrasound scans were done in the observation period.
Results: There were no technical failures. The ABI shows a significant increase from 0.52 ± 0.17 to 0.91 ± 0.25 in the follow-up. By ultrasound examination, there were found two (6.9%) restenoses during the follow-up. There was one dissection during the intervention (3.5%).
Conclusion: The rotational atherothrombectomy in combination with paclitaxel-coated angioplasty might be an effective and safe method with a promising low rate of restenosis at six months.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4406303 | PMC |
| http://dx.doi.org/10.4137/CMC.S15231 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Rotational Mechanical Thrombectomy to Treat Iliac Limb Occlusion after Endovascular Aortic Aneurysm Repair: The Rotational Mechanical Thrombectomy Italian Study.
J Vasc Interv Radiol
January 2024
Vascular and Endovascular Surgery Unit, Pederzoli Hospital, Peschiera del Garda (VR), Italy.
Article Synopsis
- The study evaluated the safety and effectiveness of a rotational mechanical thrombectomy device (Rotarex S) in patients experiencing iliac limb occlusion after abdominal endovascular aneurysm repair (EVAR).
- A retrospective analysis involved 23 male patients, averaging 74.5 years, who underwent thrombectomy for symptoms ranging from acute limb ischemia to chronic limb-threatening ischemia between 2017 to 2021.
- Results showed 100% technical success without any post-procedural deaths, with most patients receiving endograft relining; follow-up indicated low rates of reocclusion and no further interventions needed.
Effectiveness of the Rotarex Excisional Atherectomy System in Both Subacute and Chronic Aortoiliac Endograft Thrombosis: An Innovative Option for the Modern Endovascular Surgeon Toolkit.
J Endovasc Ther
December 2023
Vascular and Endovascular Surgery Unit, Santa Maria della Misericordia Hospital, University of Perugia, Perugia, Italy.
Purpose: To report a successful revascularization case using the Rotarex™S atherothrombectomy system in a recent iliac limb thrombosis, and chronic hypogastric stent obstruction after previous aortoiliac aneurysm endovascular repair (EVAR).
Case Report: A 72-year-old patient was treated for recent right iliac limb thrombosis and left iliac branch chronic hypogastric stent occlusion, 5 years after EVAR. A total endovascular approach, using both upper extremity and femoral vascular access, was settled with 2 Rotarex™S (6Fr and 10Fr) devices.
Combination of RotarexS Rotational Atherothrombectomy and Drug-Coated Balloonangioplasty for Femoropopliteal Total In-Stent Occlusion.
Ann Vasc Surg
March 2022
The Interventional Therapy department of the first Affiliated Hospital of Dalian Medical University, Dalian, China. Electronic address:
Background: Currently, there is little information on the optimal treatment for patients with femoropopliteal total in-stent occlusion.The aim of this study was to evaluate the benefit of drug-coated balloon(DCB) angioplasty after RotarexS rotational atherectomy plus thrombectomy for femoropopliteal total in-stent occlusion at 12 months.
Methods: From June 2016 to April 2019, 36 patients (21 male, mean age 71.
Percutaneous mechanical atherothrombectomy using the RotarexS device in peripheral artery in-stent restenosis or occlusion: a French retrospective multicenter study on 128 patients.
Quant Imaging Med Surg
January 2020
Department of Pharmacy, Statistics and Clinical Research, Centre Hospitalier Universitaire François-Mitterrand, Dijon, France.
Background: To ascertain the safety and mid-term outcomes of RotarexS rotational atherectomy plus thrombectomy device (Straub Medical AG, Wangs, Switzerland) with or without adjunctive treatment (e.g., percutaneous transluminal angioplasty, PTA/drug-coated balloon, DCB/stenting) in patients with in-stent restenosis (ISR) or occlusion in the iliac and/or infrainguinal arteries.
View Article and Find Full Text PDFCombination of rotational atherothrombectomy and Paclitaxel-coated angioplasty for femoropopliteal occlusion.
Clin Med Insights Cardiol
May 2015
Institute of Diagnostic and Interventional Radiology/Neuroradiology, Westkuestenklinikum Heide, Academic Teaching Hospital of the Universities of Kiel, Luebeck and Hamburg, Heide, Germany.
Objective: The rotational atherothrombectomy with Straub Rotarex(®) is a safe and efficient treatment of acute/subactute vascular occlusions. The purpose of this study was to evaluate the benefit of paclitaxel-coated angioplasty after rotational atherothrombectomy over an observation period of six months.
Materials And Methods: Overall, 29 patients were treated with the Rotarex catheter in combination with paclitaxel-coated angioplasty.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!